646 results on '"Wirtz, Hubert"'
Search Results
2. Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin–angiotensin–aldosterone system on COVID-19 disease
3. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
4. Comparative bioinformatic analysis of KRAS, STK11 and KEAP1 (co-)mutations in non-small cell lung cancer with a special focus on KRAS G12C
5. Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial
6. Lymphangioleiomyomatose
7. Molekularpathologie in der Behandlung des Lungenkarzinoms – interdisziplinärer Blick auf die thoraxchirurgische Bedeutung
8. Tabakkonsum und Behandlung von Tabakabhängigkeit: Wirksame Strategien und aktuelle Entwicklungen
9. Predictors of psychiatric comorbidity in cancer patients at the time of their discharge from the hospital
10. Cardiac function in relation to functional status and fatigue in patients with post-COVID syndrome
11. CT texture analysis and node-RADS CT score of mediastinal lymph nodes - diagnostic performance in lung cancer patients
12. Nasal high-flow compared to non-invasive ventilation in treatment of acute acidotic hypercapnic exacerbation of chronic obstructive pulmonary disease—protocol for a randomized controlled noninferiority trial (ELVIS)
13. TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations.
14. Testen Sie Ihr Fachwissen.
15. A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation
16. Effect of Nasal High Flow (NHF) on Right Heart Function in Stable Patients with Pulmonary Hypertension of Different WHO Classes
17. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
18. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
19. Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry
20. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
21. Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany
22. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
23. Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
24. Use of psychosocial services by lung cancer survivors in Germany: Results of a German multicenter study (LARIS)
25. A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation
26. Quality of Life in NSCLC Survivors — A Multicenter Cross-Sectional Study
27. Effective flow rates and decarboxylation differs between nasal high-flow devices
28. Adipokines in cachexia of patients with lung cancer
29. Nasal High-Flow (NHF) Improves Ventilation in Patients with Interstitial Lung Disease (ILD)—A Physiological Study
30. The revised GOLD 2017 COPD categorization in relation to comorbidities
31. The association of socioeconomic status with quality of life in cancer patients over a 6-month period using individual growth models
32. Lymphangioleiomyomatose
33. Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD – a retrospective analysis
34. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
35. IGFBP3 inhibits tumor growth and invasion of lung cancer cells and is associated with improved survival in lung cancer patients
36. Subjective sleep quality in sarcoidosis
37. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment
38. Decreased COPD exacerbation rates during the COVID-19 pandemic
39. Psychische Verfassung und psychosoziale Versorgungssituation von Überlebenden von kleinzelligem Lungenkrebs
40. Genetic susceptibility to hepatoxicity due to bosentan treatment in pulmonary hypertension
41. Neuropsychiatric phenotype of post COVID-19 syndrome in non-hospitalized patients
42. Mediastinalerkrankungen
43. Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study
44. The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort
45. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study
46. Mediastinalerkrankungen
47. Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
48. Erkrankungen der Atmungsorgane
49. Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial
50. Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.